382 related articles for article (PubMed ID: 28842560)
1. Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui.
Wang P; Lu P; Qu X; Shen Y; Zeng H; Zhu X; Zhu Y; Li X; Wu H; Xu J; Lu H; Ma Z; Zhu H
Sci Rep; 2017 Aug; 7(1):9451. PubMed ID: 28842560
[TBL] [Abstract][Full Text] [Related]
2. Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections.
Yang H; Li X; Yang X; Lu P; Wang Y; Jiang Z; Pan H; Zhao L; Zhu Y; Khan IU; Shen Y; Lu H; Zhang T; Jiang G; Ma Z; Wu H; Zhu H
Antiviral Res; 2019 Sep; 169():104555. PubMed ID: 31295520
[TBL] [Abstract][Full Text] [Related]
3. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.
De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM
Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142
[TBL] [Abstract][Full Text] [Related]
4. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C
PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566
[TBL] [Abstract][Full Text] [Related]
5. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response.
Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131
[TBL] [Abstract][Full Text] [Related]
6. Euphorbia Kansui Reactivates Latent HIV.
Cary DC; Fujinaga K; Peterlin BM
PLoS One; 2016; 11(12):e0168027. PubMed ID: 27977742
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.
Jiang G; Mendes EA; Kaiser P; Sankaran-Walters S; Tang Y; Weber MG; Melcher GP; Thompson GR; Tanuri A; Pianowski LF; Wong JK; Dandekar S
AIDS; 2014 Jul; 28(11):1555-66. PubMed ID: 24804860
[TBL] [Abstract][Full Text] [Related]
8. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.
Márquez N; Calzado MA; Sánchez-Duffhues G; Pérez M; Minassi A; Pagani A; Appendino G; Diaz L; Muñoz-Fernández MA; Muñoz E
Biochem Pharmacol; 2008 Mar; 75(6):1370-80. PubMed ID: 18241838
[TBL] [Abstract][Full Text] [Related]
10. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation.
Jiang G; Mendes EA; Kaiser P; Wong DP; Tang Y; Cai I; Fenton A; Melcher GP; Hildreth JE; Thompson GR; Wong JK; Dandekar S
PLoS Pathog; 2015 Jul; 11(7):e1005066. PubMed ID: 26225771
[TBL] [Abstract][Full Text] [Related]
12. Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA.
Taylor JP; Armitage LH; Aldridge DL; Cash MN; Wallet MA
Biol Open; 2020 Dec; 9(12):. PubMed ID: 33234703
[TBL] [Abstract][Full Text] [Related]
13. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
Rochat MA; Schlaepfer E; Speck RF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
[TBL] [Abstract][Full Text] [Related]
14. A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b.
Liang T; Zhang X; Lai F; Lin J; Zhou C; Xu X; Tan X; Liu S; Li L
Biochem Pharmacol; 2019 Jun; 164():237-251. PubMed ID: 30991051
[TBL] [Abstract][Full Text] [Related]
15. Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency.
Hashemi P; Barreto K; Bernhard W; Lomness A; Honson N; Pfeifer TA; Harrigan PR; Sadowski I
EMBO Mol Med; 2018 Feb; 10(2):160-174. PubMed ID: 29246970
[TBL] [Abstract][Full Text] [Related]
16. Effects of diterpenes from latex of Euphorbia lactea and Euphorbia laurifolia on human immunodeficiency virus type 1 reactivation.
Avila L; Perez M; Sanchez-Duffhues G; Hernández-Galán R; Muñoz E; Cabezas F; Quiñones W; Torres F; Echeverri F
Phytochemistry; 2010 Feb; 71(2-3):243-8. PubMed ID: 19897215
[TBL] [Abstract][Full Text] [Related]
17. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of latent HIV-1 by new semi-synthetic ingenol esters.
Pandeló José D; Bartholomeeusen K; da Cunha RD; Abreu CM; Glinski J; da Costa TB; Bacchi Rabay AF; Pianowski Filho LF; Dudycz LW; Ranga U; Peterlin BM; Pianowski LF; Tanuri A; Aguiar RS
Virology; 2014 Aug; 462-463():328-39. PubMed ID: 25014309
[TBL] [Abstract][Full Text] [Related]
19. Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors That Potently Reactivate Latent HIV.
Curreli F; Ahmed S; Victor SMB; Debnath AK
Viruses; 2020 Jun; 12(6):. PubMed ID: 32503121
[TBL] [Abstract][Full Text] [Related]
20. Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS.
Yang J; Shi C; Cheng Y; Zhu Y; Yang X; Liang Y; Liang H; Lin Q; Li M; Xun J; Liu J; Yin C; Qi J; Zhu H
Eur J Pharm Biopharm; 2024 Jun; ():114353. PubMed ID: 38885911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
